Clarksville, TN Online: News, Opinion, Arts & Entertainment.


Topic: Plasma

American Red Cross urgently needs Blood Donations during COVID-19 pandemic, upcoming Holidays

 

American Red CrossNashville, TN – The American Red Cross is urging healthy donors of all blood types to band together to give blood or platelets and help ensure a stable blood supply for patients this holiday season.

The traditional slump in blood donations between Thanksgiving and New Year’s comes as the blood supply already faces challenges created by the COVID-19 Coronavirus pandemic.

Sara Hernandez has been giving platelets since she was 18 years old. (Amanda Romney, American Red Cross)

Sara Hernandez has been giving platelets since she was 18 years old. (Amanda Romney, American Red Cross)

«Read the rest of this article»

Sections: News | No Comments
 

FDA Coronavirus (COVID-19) Update: September 3rd, 2020

 

U.S. Food and Drug Administration (FDA)Silver Spring, MD – The U.S. Food and Drug Administration (FDA) continued to take action in the ongoing response to the COVID-19 Coronavirus pandemic:

On September 1st, 2020, the FDA approved an abbreviated new drug application for cisatracurium besylate USP 20 mg/10mL, which is indicated to facilitate tracheal intubation and to provide skeletal muscle relaxation during surgery or mechanical ventilation.

Coronavirus

Coronavirus

«Read the rest of this article»

Sections: News | No Comments
 

FDA Issues Emergency Use Authorization for Convalescent Plasma as Potential Promising COVID–19 Treatment

 

Another Achievement in the Donald Trump Administration’s Fight Against Pandemic

U.S. Food and Drug Administration (FDA)Silver Spring, MD – On Sunday, August 23rd, 2020, the U.S. Food and Drug Administration issued an emergency use authorization (EUA) for investigational convalescent plasma for the treatment of COVID-19 Coronavirus in hospitalized patients as part of the agency’s ongoing efforts to fight COVID-19 Coronavirus.

Coronavirus.

Coronavirus.

«Read the rest of this article»

Sections: News | No Comments
 


Plasma Therapy a Promising Step in Fight Against COVID-19

 

The White HouseWashington, D.C. – “On Sunday, President Trump announced the U.S. Food and Drug Administration is issuing an emergency use authorization for (EUA) convalescent plasma in hospitalized patients, another step forward in the fight against COVID-19 Coronavirus,” Dr. Nicole Saphier writes for Fox News.

“It may not be the magic ticket to end the pandemic, but can it save lives if sufficient quantities of IgG [antibodies] are given early enough? Data from over 30,000 people in the study suggest so. And because of that, every American should be rejoicing.”

The White House - West Wing. (Official White House Photo) «Read the rest of this article»

Sections: Politics | No Comments
 

President Donald Trump to recovered Coronavirus Patients, Your plasma could save lives

 

The White HouseWashington, D.C. – President Donald Trump just visited the American Red Cross Headquarters, where he joined public health experts from across the government to discuss a promising new development in the fight against COVID-19 Coronavirus.
 
New research shows that the plasma from recovered COVID-19 Coronavirus patients could help those who are currently battling the disease. The Red Cross and America’s Blood Centers together will receive up to $270 million from the Administration for the collection of up to 360,000 units of plasma for this purpose.

President Donald Trump participates in a tour of the Red Cross National Headquarters. (White House)

President Donald Trump participates in a tour of the Red Cross National Headquarters. (White House)

«Read the rest of this article»

Sections: Politics | No Comments
 

FDA releases Coronavirus Update

 

U.S. Food and Drug Administration - FDASilver Spring, MDThe U.S. Food and Drug Administration (FDA) has announced the following actions taken in its ongoing response effort to the Coronavirus (COVID-19) pandemic:

The FDA announced that it is leading an effort, working collaboratively with government, industry and academic partners, to develop and implement a protocol that will provide convalescent plasma to patients in need across the country who may not have access to institutions with clinical trials in place. 

Coronavirus

Coronavirus

«Read the rest of this article»

Sections: News | No Comments
 

FDA Coronavirus (COVID-19) Update for April 3rd, 2020

 

U.S. Food and Drug Administration - FDASilver Spring, MDThe U.S. Food and Drug Administration (FDA) continues to play a critical role in accelerating medical countermeasures to treat and prevent Coronavirus (COVID-19).

As part of the response to this pandemic, the agency is taking the lead on a national effort to facilitate the development of, and access to, two investigational therapies derived from human blood.

Coronavirus

Coronavirus

«Read the rest of this article»

Sections: News | No Comments
 


FDA releases Coronavirus Update, Daily Roundup

 

U.S. Food and Drug Administration - FDASilver Spring, MDThe U.S. Food and Drug Administration (FDA) has announced the following actions taken in its ongoing response effort to the coronavirus COVID-19 pandemic:

The FDA is facilitating access to convalescent plasma, antibody-rich blood products that are taken from blood donated by people who have recovered from the coronavirus COVID-19 virus, that could shorten the length, or lessen the severity, of the illness.

Coronavirus

Coronavirus

«Read the rest of this article»

Sections: News | No Comments
 

NASA’s Parker Solar Probe discovers new insights about our Sun

 

NASA - National Aeronautics and Space AdministrationGreenbelt, MD – In August 2018, NASA’s Parker Solar Probe launched to space, soon becoming the closest-ever spacecraft to the Sun. With cutting-edge scientific instruments to measure the environment around the spacecraft, Parker Solar Probe has completed three of 24 planned passes through never-before-explored parts of the Sun’s atmosphere, the corona.

On December 4th, 2019, four new papers in the journal Nature describe what scientists have learned from this unprecedented exploration of our star — and what they look forward to learning next.

Illustration of Parker Solar Probe. (NASA/Johns Hopkins APL)

Illustration of Parker Solar Probe. (NASA/Johns Hopkins APL)

«Read the rest of this article»

Sections: Technology | No Comments
 

NASA’s Voyager 2 spacecraft entered Interstellar Space One Year Ago Today

 

NASA - National Aeronautics and Space AdministrationPasadena, CA – On November 5th, 2018, NASA’s Voyager 2 became only the second spacecraft in history to leave the heliosphere – the protective bubble of particles and magnetic fields created by our Sun. At a distance of about 11 billion miles (18 billion kilometers) from Earth – well beyond the orbit of Pluto – Voyager 2 had entered interstellar space, or the region between stars.

Today, five new research papers in the journal Nature Astronomy describe what scientists observed during and since Voyager 2’s historic crossing.

This artist's concept shows one of NASA's Voyager spacecraft entering interstellar space, or the space between stars. This region is dominated by plasma ejected by the death of giant stars millions of years ago. Hotter, sparser plasma fills the environment inside our solar bubble. (NASA)

This artist’s concept shows one of NASA’s Voyager spacecraft entering interstellar space, or the space between stars. This region is dominated by plasma ejected by the death of giant stars millions of years ago. Hotter, sparser plasma fills the environment inside our solar bubble. (NASA)

«Read the rest of this article»

Sections: Technology | No Comments
 



  • Visit Us On FacebookVisit Us On TwitterVisit Us On PinterestVisit Us On YoutubeCheck Our FeedVisit Us On Instagram
  • Personal Controls

    Now playing at the Movies